Rubella causes disease in the fetus. Immunity to rubella is therefore, routinely screened in pregnant women. In this retrospective observational study, we assessed the levels of potential susceptibility to rubella in the population of a north London antenatal clinic. Risk factors for potential susceptibility to rubella and changes in potential susceptibility to rubella over time were studied. Almost all women were screened for potential susceptibility to rubella (99.8%).
| INTRODUCTION
Rubella is an important pathogen affecting the fetus. Primary infection in the first trimester can cause congenital heart disease, sensorineural hearing loss, and cataracts. 1 Prior to the UK vaccination program, around one in five women remained susceptible to rubella with hundreds of cases of congenital rubella syndrome (CRS). 2 Rubella infection and CRS are now rare in the UK, with 23 infants diagnosed with CRS since 2000. 3 In the majority of these cases rubella was acquired abroad. 3 Worldwide, however, an estimated 110 000 babies are born with CRS every year. 4 In the UK, a national immunization program for adolescent girls began in 1970 using measles/rubella combined vaccine. 1 This was later replaced by universal measles/mumps/rubella (MMR) combined vaccine for toddlers in 1988. 1 Since the 1970s, women at antenatal booking clinics have been routinely screened for immunity to rubella through testing for IgG antibodies specific to rubella. It is recommended that individuals found to be non-immune receive MMR vaccine postpartum. This activity will shortly cease, because the Joint Committee on Vaccination and Immunization has recently recommended that immunity to rubella should be assessed solely by MMR vaccination history. 5 Because of this planned change, we took the opportunity to review potential susceptibility to rubella within our antenatal screening program before screening ceases. Potential susceptibility to rubella in the antenatal population of a north London hospital were determined.
Risk factors for potential susceptibility to rubella and changes in potential susceptibility over the study period were assessed.
Details of ethics approval: The study was registered with the local Governance department and subject to their standards. Use of clinical data was approved by the local NHS Trust Governance Committee, including retrospective use of women's demographic data and test results. Approval was granted on 9th September 2014.
multivariate analysis, it was analyzed as continuous numerical data without stratification.
Year of booking was taken as the date of the electronic maternal booking form.
As the assay used for screening was not a gold standard immunoblot or neutralization assay, individuals in whom antibody levels did not meet the threshold are described as "potentially susceptible." Analysis is presented with an antibody threshold of 5 IU/mL. This level was chosen taking into account recent discussion regarding which threshold best correlates with protection against infection from rubella. To elaborate, the UK National Screening Committee recommends defining susceptibility to rubella as having antibody levels less than 10 IU/mL. 8 However, using the recommended practice of a 10 IU/mL threshold for immunity has been reported to lack sensitivity. 9 Over half of samples falling below 10 IU/mL threshold when tested using the Abbott Architect assay were found to be positive for antibodies against rubella by the gold standard methods of immunoblot and neutralization assays. 9 Around 2/3 of these false-negatives fell into the equivocal category on the Abbott Architect (5-10 IU/mL). This may lead to some individuals with a concentration of rubella IgG below 10 IU/mL being incorrectly designated as "susceptible" to rubella infection. The lower level of 5 IU/mL is also supported by previous modeling which has suggested antibody levels <5 IU/mL may more accurately represent women susceptible to infection. 10 In this study from Canada, where rubella is eliminated, 11 a retrospective study showed 1/3 of vaccinated individuals had IgG levels that were below the designated threshold of immunity after 15 years. 10 Given sustained elimination of rubella virus in Canada, the authors argue that low levels of rubella-specific antibodies below 10 IU/mL threshold for immunity may be sufficient to prevent reintroduction and the spread of infection. 
| Year of booking
Differences in potential susceptibility to rubella of women booking in different years within the study period were analyzed using univariate analysis. Women booking in 2010 showed significantly lower rates of potential susceptibility to rubella (2.5%), which increased in subsequent years: 2011, 2.8%; 2012, 3.4%; 2013, 4.1%; 2014, 3.4%.
(P = 0.003).
| Ethnicity
A total of 92.2% (13 021/14 118) of women declared an ethnicity at booking. There was a significant difference between the rate of potential susceptibility in those declaring an ethnicity ("White" or "Non-white or mixed") compared to those without an ethnicity recorded ("Unknown") (3.1% vs 4.6%, P = 0.003) Those identifying as a "White" ethnicity were less likely to be potentially susceptible to rubella (169/7830, 2.2%) compared to those of other ethnicities (226/5173, 4.4%) P < 0.001).
| Previous pregnancy
At individuals' first booking within the study period 6017/14 118 (42.6%)
reported no previous pregnancies. Previous pregnancy was identified as protective factor against potential susceptibility to rubella at booking in univariate analysis. (209/8090; 2.6% vs 237/6010; 3.9%,).
| Number of bookings in study period
Number of booking appointments within the study period was not associated with potential susceptibility to rubella in univariate analysis.
Potential susceptibility in those with only one booking was not significantly different (n = 396/12 154; 3.3%) than in those with multiple bookings (n = 50/1946; 2.6%) (P = 0.10).
| Country of birth
Country of birth was investigated as a risk factor for potential susceptibility to rubella IgG. A total of 10 548/1410 (74.8%) of individuals had both a country of birth recorded and a rubella IgG test performed. The rate of potential susceptibility to rubella in those with a country of birth recorded was not significantly different from those who did not have a country of birth recorded (329/10 548, 3.1% vs 117/3435, 3.3%, P = 0.6).
Being born outside of the British Isles was a significant risk factor for potential susceptibility to rubella. The proportion of those born outside the British Isles being potentially susceptible rubella was 265/6960 (3.8%) compared to 64/3588 (1.8%) to those born inside the British Isles (P < 0.001). Being from a country at high-risk of potential susceptibility to rubella significantly increased the risk of being potentially susceptible to rubella at booking (129/2223, 5.8% vs 317/11 877, 2.4% P < 0.001).
| Multivariate analysis
Logistical regression was used to investigate the effect size of these individual factors and to minimise confounding. Age, ethnicity, previous pregnancy, year of booking, number of bookings within the study period and individuals' country of birth were analyzed using a multivariate binary regression model using the threshold for immunity of 5 IU/mL (Table 2) .
Age remained a significant predictor of immunity to rubella. For every year older there was a 5.1% increased chance of having antibodies above the threshold for predicted immunity to rubella (CI:
3.3%, 6.9%, P < 0.001).
Ethnicity was also independently associated with potential susceptibility to rubella. Those from a non-white ethnicity were Being born in a high-risk country for potential susceptibility to rubella was a significant predictor of potential susceptibility to rubella in our sample. Those born in a high-risk country had around a 50% odds of having antibodies above the immunity threshold predicted to
give rubella immunity (OR 0.545 CI: 0.316, 0.774, P < 0.001) compared to those from a low-risk country.
Previous pregnancy was a protective factor against potential susceptibility to rubella. Individuals with at least one previous pregnancy had an odds ratio of 1.41 (CI 1.21,1.61, P = 0.001) of having rubella antibodies above the threshold for predicted immunity to rubella compared to those with no previous pregnancy.
Year of initial booking within the study period was associated with differences in immunity to rubella. Each successive year of the study period was associated with an odds ratio of 0.909 of reaching the threshold predicted to provide immunity against rubella (OR: 0.909, CI:
0.836, 0.981, P = 0.009).
Number of bookings within the study period failed to reach significance in the multivariate analysis (P = 0.37).
| DISCUSSION
The rubella screening program assesses the susceptibility of pregnant women to rubella infection. In this study over 99% of the antenatal population attending our hospital for booking were screened for potential susceptibility to rubella, confirming good implementation of this testing policy. This study also confirms that the vast majority of women seeking antenatal care in North London are predicted to be immune to rubella, detecting antibodies above the recommended 10 IU/mL threshold in 92.8% of women at first booking. When the lower limit of 5 IU/mL is used, over 95% of the study population had antibodies likely to be protective against rubella.
The level of predicted immunity to rubella seen in this study is above minimum estimates of critical prevalence of rubella immunity required to prevent an outbreak. 12 When the lower limit is used, predicted immunity levels reach the 95% level recommended for childbearing women by the 2003 WHO European strategic plan.
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Potentially susceptible women are still at risk from rubella infection from imported cases and travel to areas where rubella is endemic.
Risk factors for potential susceptibility to rubella include age.
Rates of potential susceptibility to rubella are increased in younger women. Indeed women under 20 at first booking had the highest levels of potential susceptibility to rubella, reaching the 5 IU/mL threshold in just 91.5%. The levels of potential susceptibility to rubella in this age group are around 2.5 times higher than in those aged 40 and over.
The reasons for increases in potential susceptibility with younger women are unclear. This change may relate to declining rates of vaccine uptake over time. Previous, widely reported data showed that vaccine uptake for the MMR vaccine fell after 1998, associated with the MMR-autism scandal. 13 PHE data confirms this, after the MMR vaccine was introduced in 1988 the level of coverage was consistently around 90%, until falling gradually after 1998-79.9% in 2003/4.
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The youngest women in our cohort, aged between 14 and 25 and with the highest levels of potential susceptibility to rubella, would have been vaccinated between 1990 and 2002. Thus we can hypothesize that the relationship between age and potential susceptibility found in our study may be at least in part attributable to decreasing vaccine uptake. Unfortunately, our dataset did not include information on individuals' vaccination history, so we were unable to test this hypothesis further.
Potential susceptibility across the study period increased 2009, the susceptibility of childbearing women was found to increase by 60% in England from 2.1% to 3.5%. 15 Over a similar time period in the West Midlands, susceptibility in pregnant women increased around five times to around 7%. 16 These results are broadly similar to our findings.
Increases in potential susceptibility in later years may be attributable to several factors. Firstly, it may reflect the fact that indigenous rubella circulates at very low levels, if at all. 17 Immunity in more recent years is therefore, solely attributable to vaccination, to limited transmission from imported cases or exposure to rubella in other countries. One potential explanation is that changes in potential susceptibility across the study period are confounded by changes in the country of birth of women within the sample across time. Table 3 compares proportions of individuals across the study period who were born in "high-risk countries." There is a significant difference between the proportion of individuals from a high-risk country of birth in different years across the study period (P < 0.001). However, this difference is small and unlikely to account for changes in susceptibility across different years in the study period. Furthermore, in the multivariate analysis both the year of booking and being from a high- Proportion of individuals potentially susceptible to rubella stratified by age and country of birth risk country of birth are significant predictors of potential susceptibility. This suggests any relationship between year of booking and being from a high-risk country of birth does not confound the effect each factor has on potential susceptibility.
Country of birth was associated with differences in potential susceptibility to rubella. Women born outside the British Isles or in countries where vaccination program are known to be inadequate or where vaccination is not universally recommended were at increased risk of potential susceptibility to rubella. These two factors exist independent of each other in multivariate analysis, suggesting being born in a high-risk country conveys a heightened risk of potential susceptibility independently of that given by being born outside the UK.
The relationship between age and country of birth was investigated (Fig. 1) . Patterns of susceptibility in different age groups were broadly similar independently of whether individuals were born inside or outside the British Isles. Susceptibility was highest in those <20, with lower numbers of susceptible individuals in later age groups.
There was a second peak of susceptibility in those over 40 in both those born in the British Isles and those born outside. This suggests any relationship between potential susceptibility and country of birth exists independently and is not confounded by age.
Ethnicity was also predictive of potential susceptibility to rubella in the multivariate analysis. Unfortunately our data for ethnicity was incomplete, and there was significant difference in potential susceptibility in those who did not have ethnicity recorded compared to those that did. As such our analysis that ethnicity is a significant risk factor for potential susceptibility may be erroneous. Furthermore, it is not clear whether those without ethnicity recorded are more likely to be fall into "white" or "non-white" categories. We therefore, cannot comment on whether the odds ratio for ethnicity is likely to be an overestimate or underestimate. With this caveat, our data showed those from non-white backgrounds were more likely to be potentially susceptible. This mirrors other studies which have previously identified women of childbearing age from non-white ethnic groups as significantly more likely to lack immunity to rubella. 15, 18 Our multivariate analysis acts to limit the confounding factor of country of birth from ethnicity. Indeed, this data suggests those from ethnic minorities are more likely to be susceptible to rubella independent of their country of birth.
This study is a topical assessment of potential susceptibility to rubella in an at-risk population just before routine screening ceases. It confirms that the vast majority of antenatal women attending our clinic show evidence of immunity to rubella. As such, screening is unlikely to have benefit for these women. There exists a small but significant proportion of women potentially susceptible to rubella infection. We have identified risk-factors which may aid identification of those potentially susceptible to rubella infection. As routine screening for all women has been recommended to cease, a potential strategy for identifying those potentially susceptible to rubella infection include relying solely on vaccination history. As the vaccination history of women was unavailable it is unclear if vaccination history would be sufficient to identify potential susceptible individuals. Alternatively, selectively screening patients from highrisk categories could identify those who are potentially susceptible.
At present, seronegative women are protected while they remain in the UK, because the incidence of confirmed rubella suggests circulating rubella is eliminated from England and Wales. 17 However, they could be exposed through travel abroad or by contact with imported cases of rubella. An important practice point is that healthcare professionals, especially GPs and obstetricians, could actively offer screening for rubella immunity to women with risk factors for potential susceptibility and administer vaccine to those who are found to be seronegative.
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